Zhu, Mingqin
Wang, Xiuzhe
Hjorth, Erik
Colas, Romain A.
Schroeder, Lisa
Granholm, Ann-Charlotte
Serhan, Charles N.
Schultzberg, Marianne
Funding for this research was provided by:
The Swedish Research Council (22743 and 22744)
The Chinese Scholarship Council
Swedish Brain Power
The Knut and Alice Wallenberg Foundation
Karolinska Institutet research funds
The Swedish Alzheimer Foundation
Stiftelsen för Gamla Tjänarinnor
Gun och Bertil Stohnes Stiftelse
Barmore Fund
National Institutes of Health (P01GM095467, GM038765)
Article History
Received: 11 June 2015
Accepted: 15 November 2015
First Online: 9 December 2015
Compliance with ethical standards
:
: C.N.S. has the following disclosures: as inventor on patents [resolvins] assigned to BWH and licensed to Resolvyx Pharmaceuticals, scientific founder of Resolvyx Pharmaceuticals with equity ownership in the company, and has interests reviewed and managed by the Brigham and Women’s Hospital and Partners Health Care in accordance with their conflict of interest policies.